DISPOSITION OF ORAL QUININE IN ACUTE FALCIPARUM-MALARIA

被引:49
作者
SUPANARANOND, W
DAVIS, TME
PUKRITTAYAKAMEE, S
SILAMUT, K
KARBWANG, J
MOLUNTO, P
CHANOND, L
WHITE, NJ
机构
[1] MAHIDOL UNIV, FAC TROP MED, 420-6 RAJVITHI RD, BANGKOK 10400, THAILAND
[2] JOHN RADCLIFFE HOSP, NUFFIELD DEPT CLIN MED, OXFORD OX3 9DU, ENGLAND
[3] PAHOLPOLPAYUHASENA HOSP, KANCHANABURI, THAILAND
基金
英国惠康基金;
关键词
QUININE; PHARMACOKINETICS; FALCIPARUM MALARIA;
D O I
10.1007/BF00315138
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Plasma quinine concentrations following oral quinine sulphate 10 mg salt/kg have been measured by HPLC in 15 adult Thai patients with uncomplicated falciparum malaria. In 10 of the same patients the study was repeated in convalescence. In acute malaria plasma concentrations were approximately 50% higher than in convalescence; the mean acute peak plasma quinine concentration was 8.4 mg.l-1 compared to 5.7 mg.l-1 in convalescence. There was considerable variation in the rate of drug absorption, particularly in acute malaria. The mean time to peak plasma concentration was 5.9 h in acute malaria and 3.2 h in convalescence. The apparent clearance of oral quinine (CL/f) during the illness was 1.51 ml.kg-1.min-1, which was significantly lower than in convalescence - 2.67 ml.kg-1.min-1. Estimated free quinine clearance was also lower in the acute phase: 30.6 compared to 49.0 ml.kg-1.min-1 in convalescence. Mean (SD) plasma protein binding of quinine was 94.7% in acute malaria and 92.8% in convalescence. Binding was significantly correlated with the plasma concentration of alpha-1 acid glycoprotein (r = 0.5), which was significantly higher in the acute phase; 1.48 g.l-1 compared to 1.05 g.l-1 during convalescence. Oral quinine sulphate was well absorbed in uncomplicated falciparum malaria. High blood concentrations following the administration of oral quinine in acute malaria are probably related to increased plasma protein binding, lower apparent volume of distribution, and a reduction in its systemic clearance.
引用
收藏
页码:49 / 52
页数:4
相关论文
共 13 条
[1]  
BROOKS MH, 1969, CLIN PHARMACOL THER, V10, P85
[2]   QUANTIFICATION OF QUININE IN HUMAN-SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
EDSTEIN, M ;
STACE, J ;
SHANN, F .
JOURNAL OF CHROMATOGRAPHY, 1983, 278 (02) :445-451
[3]  
GARNHAM JC, 1976, J TROP MED HYG, V79, P264
[4]  
HALL AP, 1975, SEATO ANN PROGR REPO, P240
[5]   RELATIVE BIOAVAILABILITY OF THE HYDROCHLORIDE, SULFATE AND ETHYL CARBONATE SALTS OF QUININE [J].
JAMALUDIN, A ;
MOHAMAD, M ;
NAVARATNAM, V ;
SELLIAH, K ;
TAN, SC ;
WERNSDORFER, WH ;
YUEN, KH .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (02) :261-263
[6]  
KARBWANG J, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P55
[7]   PHARMACOKINETICS OF QUININE IN CHILDREN [J].
SHANN, F ;
STACE, J ;
EDSTEIN, M .
JOURNAL OF PEDIATRICS, 1985, 106 (03) :506-510
[8]   BINDING OF QUININE TO PLASMA-PROTEINS IN FALCIPARUM-MALARIA [J].
SILAMUT, K ;
WHITE, NJ ;
LOOAREESUWAN, S ;
WARRELL, DA .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1985, 34 (04) :681-686
[9]   STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS .3. THE PHYSIOLOGICAL DISPOSITION AND ANTIMALARIAL ACTIVITY OF THE CINCHONA ALKALOIDS [J].
TAGGART, JV ;
EARLE, DP ;
BERLINER, RW ;
ZUBROD, CG ;
WELCH, WJ ;
WISE, NB ;
SCHROEDER, EF ;
LONDON, IM ;
SHANNON, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1948, 27 (03) :80-86
[10]  
TRENHOLME GM, 1976, CLIN PHARMACOL THER, V19, P459